For healthcare providers
Evira for regions and childhood obesity clinics
Childhood obesity requires long-term treatment, but a large part of the treatment takes place between visits. Evira is a digital treatment support that enables the treatment team to continuously monitor progress and direct efforts where they are most needed – within the care pathway you already have.
Treatment at home and at the clinic
At home
The child weighs themselves on a numberless smart scale. The family follows development in the app together with their treatment goals.
At the clinic
The treatment team sees development in the clinic interface and can prioritise the patients who need contact first.
Connection to national care programmes and close care
The national care programme for childhood obesity describes combined lifestyle treatment as the foundation and digital treatment support as a possible part of intensive interventions. Evira is mentioned there as a digital treatment support.
For regions, the working method is close to the development towards self-monitoring and close care: measurements take place at home, while assessment and treatment decisions remain with the treatment team.
Before and with Evira
| Without digital support | With Evira |
|---|---|
| Development between visits is unknown. | The treatment team can continuously monitor weight development. |
| Weight is measured in front of the child at the clinic. | The child weighs themselves at home without seeing the number. |
| All patients follow the same visit frequency. | Contacts can be directed where the need is greatest. |
| The family lacks support between visits. | The family has goals, visualisation and a contact path in the app. |
Five questions to address before a decision
1. Which problem should be solved?
For example, limited follow-up between visits, long waiting times or unequal access to treatment in the region.
2. Which patient group is affected?
Age, degree of obesity, care level and number of patients in current treatment.
3. How does it fit into the care pathway?
Which visits, contacts and decision points currently exist and what should be changed.
4. Who is responsible for what?
The healthcare provider has care and personal data responsibility. Evira is the personal data processor and is responsible for the platform.
5. How is the result followed up locally?
Which metrics you want to track, for example BMI-SDS development, participation and treatment continuity.
How an implementation works
- 1
Review
We review the current situation, the patient group and what you want to achieve.
- 2
Agreement and data protection
Personal data processing agreement and documentation for your risk assessment and DPIA.
- 3
Team start-up
Accounts, roles and training for the treatment team.
- 4
First patients
You start with a limited number of patients in the existing care pathway.
- 5
Follow-up and scale-up
Evaluation together with us and gradual expansion at your chosen pace.
No local installation is required and you do not need to change your journal system. Read more about implementation at the clinic
Patient data, security and responsibility
The healthcare provider is the personal data controller and retains medical responsibility. Evira is responsible for the platform as a personal data processor.
- CE-marked medical device according to MDR, Class I
- Evira is the personal data processor, the healthcare provider is the data controller
- Two-factor authentication for healthcare staff
- Encryption in transit and storage
- Operation and storage within the EU/EEA
- Logging and access control
- Basis for DPIA, information security and procurement
Evidence
In a pragmatic study with 107 children and adolescents using Evira, compared to 321 matched patients receiving standard treatment, the mean change in BMI-SDS was −0.30 after one year.
In the three-year follow-up, the adjusted change in BMI Z-score was −0.29 with Evira compared to −0.12 with standard treatment.
The impact on your own healthcare production and cost needs to be calculated locally based on your care pathway and patient volume. We are happy to share documentation for this calculation.
Regions and clinics using Evira
Region Kronoberg
Digital obesity treatment for children and young people aged 6–18 at the Paediatric and Adolescent Clinic, with daily home weigh-ins and close contact with the clinic.
Read the case studyRegion Jämtland Härjedalen
The childhood obesity team in Östersund uses Evira as digital treatment support. After an initial pilot period, Evira is now included in the region's care programme.
Read the case studyRegion Jönköpings län
Evira is used as digital treatment support within the child and adolescent medicine clinics in Jönköping, Värnamo, and Eksjö.
Read the case studyBarnsjukhuset Martina
One of Evira's earliest healthcare providers. The first 107 patients formed the basis for the first clinical study, and today Evira is used in six paediatric and adolescent medicine clinics.
Read the case studyMeliva
Evira is used within Meliva's paediatric and adolescent medicine clinics in Solna, Sollentuna and Skärholmen as a shared digital treatment support.
Read the case studyCapio Alva
Capio Alva introduced Evira at its four paediatric and adolescent medicine clinics to create closer contact with families without more physical visits.
Read the case study
Start with the care pathway, not the technology
Book a demo and we will look together at your patient group, your patient flows and where digital follow-up would make the biggest difference.